Novo Nordisk Drops Bombshell in Knockoff Drug Scandal

Was $HIMS pushing fake weight-loss meds? This episode of Sue Wall Street unpacks the explosive class action against Hims & Hers Health after Novo Nordisk cut ties, accusing them of selling unauthorized semaglutide. We break down the lawsuit, the FDA compliance issues, and the stock’s 34% crash. Perfect for retail investors, financial watchdogs, and Wall Street skeptics. Expect legal drama, corporate accountability, and deep dives into public health risk and securities fraud.

We’re not lawyers or accountants, so don’t take this as legal or financial advice.